NTX-001, a drug-device combination by Neuraptive Therapeutics, has received Breakthrough Therapy Designation from the FDA for treating peripheral nerve injuries requiring repair.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.